Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

The biological significance of methylome differences in human papilloma virus associated head and neck cancer.

Worsham MJ, Chen KM, Datta I, Stephen JK, Chitale D, Gothard A, Divine G.

Oncol Lett. 2016 Dec;12(6):4949-4956. doi: 10.3892/ol.2016.5303. Epub 2016 Oct 21.

2.

Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.

Newman LA, Stark A, Chitale D, Pepe M, Longton G, Worsham MJ, Nathanson SD, Miller P, Bensenhaver JM, Proctor E, Swain M, Patriotis C, Engstrom PF.

JAMA Oncol. 2017 Aug 1;3(8):1102-1106. doi: 10.1001/jamaoncol.2016.5598.

3.

Investigation into the presence of human papillomavirus in patients with obstructive sleep apnea.

Baldwin BJ, Chitale D, Chen KM, Worsham MJ, Yaremchuk K.

Laryngoscope. 2017 May;127(5):1231-1234. doi: 10.1002/lary.26175. Epub 2016 Jul 14.

PMID:
27412085
4.

Biological significance of genome-wide DNA methylation profiles in keloids.

Jones LR, Greene J, Chen KM, Divine G, Chitale D, Shah V, Datta I, Worsham MJ.

Laryngoscope. 2017 Jan;127(1):70-78. doi: 10.1002/lary.26063. Epub 2016 Jun 16.

PMID:
27312686
5.

Methylation Markers for Early Detection and Differentiation of Follicular Thyroid Cancer Subtypes.

Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ.

Cancer Clin Oncol. 2015 Nov;4(2):1-12. Epub 2015 Jun 15.

6.

Causal network analysis of head and neck keloid tissue identifies potential master regulators.

Garcia-Rodriguez L, Jones L, Chen KM, Datta I, Divine G, Worsham MJ.

Laryngoscope. 2016 Oct;126(10):E319-24. doi: 10.1002/lary.25958. Epub 2016 Mar 18.

PMID:
26990118
7.

Genome-Wide Scan for Methylation Profiles in Keloids.

Jones LR, Young W, Divine G, Datta I, Chen KM, Ozog D, Worsham MJ.

Dis Markers. 2015;2015:943176. doi: 10.1155/2015/943176. Epub 2015 May 14.

8.

Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer.

Worsham MJ, Chitale D, Chen KM, Datta I, Divine G.

Med Oncol. 2015 May;32(5):142. doi: 10.1007/s12032-015-0565-3. Epub 2015 Mar 25.

PMID:
25805566
9.

IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Chen KM, Stephen JK, Havard S, Mahan M, Divine G, Worsham MJ.

JAMA Otolaryngol Head Neck Surg. 2015 Mar;141(3):257-63. doi: 10.1001/jamaoto.2014.3393.

PMID:
25569158
10.

Human papilloma virus (HPV) modulation of the HNSCC epigenome.

Stephen JK, Worsham MJ.

Methods Mol Biol. 2015;1238:369-79. doi: 10.1007/978-1-4939-1804-1_20.

PMID:
25421671
11.

Incidence of keloid and risk factors following head and neck surgery.

Young WG, Worsham MJ, Joseph CL, Divine GW, Jones LR.

JAMA Facial Plast Surg. 2014 Sep-Oct;16(5):379-80. doi: 10.1001/jamafacial.2014.113. No abstract available.

PMID:
24903020
12.

Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma.

Stephen JK, Divine G, Chen KM, Chitale D, Havard S, Worsham MJ.

Cancer Clin Oncol. 2013;2(1):51-61.

13.

Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC.

Worsham MJ, Chen KM, Ghanem T, Stephen JK, Divine G.

Otolaryngol Head Neck Surg. 2013 Sep;149(3):409-16. doi: 10.1177/0194599813490895. Epub 2013 Jun 4.

14.

Improved survival with HPV among African Americans with oropharyngeal cancer.

Worsham MJ, Stephen JK, Chen KM, Mahan M, Schweitzer V, Havard S, Divine G.

Clin Cancer Res. 2013 May 1;19(9):2486-92. doi: 10.1158/1078-0432.CCR-12-3003. Epub 2013 Mar 26.

15.

Human papilloma virus prevalence in a multiethnic screening population.

Chen KM, Stephen JK, Ghanem T, Stachler R, Gardner G, Jones L, Schweitzer VP, Hall F, Divine G, Worsham MJ.

Otolaryngol Head Neck Surg. 2013 Mar;148(3):436-42. doi: 10.1177/0194599812471938. Epub 2013 Jan 8.

16.

Distinct Gene Profiles for Tumor and Non-Tumor Tissue in the Head and Neck: An Analytical Approach.

Lu M, Stephen JK, Chen KM, Havard S, Worsham MJ.

J Cancer Sci Ther. 2011 Dec 7;S1:1.

17.

Molecular characterization of head and neck cancer: how close to personalized targeted therapy?

Worsham MJ, Ali H, Dragovic J, Schweitzer VP.

Mol Diagn Ther. 2012 Aug 1;16(4):209-22. doi: 10.2165/11635330-000000000-00000.

18.

Malignant and nonmalignant gene signatures in squamous head and neck cancer.

Worsham MJ, Lu M, Chen KM, Stephen JK, Havard S, Schweitzer VP.

J Oncol. 2012;2012:752860. doi: 10.1155/2012/752860. Epub 2012 Apr 12.

19.

Disparate molecular, histopathology, and clinical factors in head and neck squamous cell carcinoma racial groups.

Worsham MJ, Stephen JK, Lu M, Chen KM, Havard S, Shah V, Schweitzer VP.

Otolaryngol Head Neck Surg. 2012 Aug;147(2):281-8. doi: 10.1177/0194599812440681. Epub 2012 Mar 12.

20.

Delineating an epigenetic continuum in head and neck cancer.

Worsham MJ, Stephen JK, Chen KM, Havard S, Shah V, Gardner G, Schweitzer VG.

Cancer Lett. 2014 Jan 28;342(2):178-84. doi: 10.1016/j.canlet.2012.02.018. Epub 2012 Mar 1. Review.

Supplemental Content

Loading ...
Support Center